Public Company News

Ascletis Announces IND Approval of Oral RdRp Inhibitor ASC10 for COVID-19 by China NMPA

-- Ascletis is China's first biotech company which has obtained IND approvals of an oral RdRp inhibitor from both China NMPA and the U.S. FDA -- Ascletis has filed multiple patent applications for ASC10 and its use globally. Compared with molnupiravir, ASC10 has a new and differentiated chemical...

2022-08-22 08:10 4047

ROYAL CANADIAN MINT REPORTS PROFITS AND PERFORMANCE FOR Q2 2022

OTTAWA, ON, Aug. 19, 2022 /PRNewswire/ -- The Royal Canadian Mint (the "Mint") is pleased to announce its financial results for the second quarter of 2022 that provide insight into its activities, the markets influencing its businesses and its expectations for the next 12 months. "The Mint conti...

2022-08-19 22:30 4939

TCL Electronics (01070.HK) Gross Profit Bucks the Trend for Growth in 2022 H1

Innovative Business Including Photovoltaic Has Become the New Growth Curve HONG KONG, Aug. 19, 2022 /PRNewswire/ -- TCL Electronics Holdings Limited ("TCL Electronics" or "the Company", 01070.HK) announced today its interim results for the six months ended30 June 2022. In the first half of 2022,...

2022-08-19 21:22 5313

Sungrow is Listed in Forbes China's Top 50 Most Innovative Companies

HEFEI, China, Aug. 19, 2022 /PRNewswire/ -- Sungrow, the global leading inverter and energy storage solution supplier for renewables, announced that it is listed inForbes China's Top 50 Most innovative companies and is the only inverter company listed. This honour reaffirms Sungrow's years-lon...

2022-08-19 15:52 4849

Angel Yeast Brings Latest Innovative Products and Solutions to FIC 2022

GUANGZHOU, China, Aug. 19, 2022 /PRNewswire/ -- Angel Yeast , (SH600298), a globally listed yeast and yeast extract manufacturer, showcased its latest yeast and yeast extract products, health ingredients, and fermentation ingredients alongside its wide range of innova...

2022-08-19 15:50 3986

Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ

Data results will be available in Q1 2023 GAITHERSBURG, Md. and SUZHOU, China, Aug. 19, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Compa...

2022-08-19 13:31 3443

Goodix Cooperates with Tuya to Pioneer the Smart Tracker Market with a Smart Tag Solution

SHENZHEN, China, Aug. 19, 2022 /PRNewswire/ -- Together with Tuya Smart (NYSE: TUYA, HKEX: 2391), a global IoT development platform service provider, Goodix (603160.SH) has developed a Smart Tag solution that supports Apple's ecology based on the GR551x series Bluetooth Low Energy SoC. Featured ...

2022-08-19 12:00 3401

Completion Of Subject Enrollment And Vaccination For The Comparative Study Between ReCOV And mRNA Vaccines

TAIZHOU, China, Aug. 19, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Company has completed the subject enrollment and dosing for the comparative Phase II clinical trial between its recombina...

2022-08-19 11:29 3971

Maoyan Entertainment Announces Interim Results for the First Half of 2022

BEIJING, Aug. 18, 2022 /PRNewswire/ -- Maoyan Entertainment ("Maoyan" or the "Company", 1896.HK), a leading platform providing innovative Internet empowered entertainment services inChina, today announced its audited consolidated results for the six months endedJune 30, 2022. First Half 2022 Fin...

2022-08-18 22:18 4522

JCET Performance Hits Another Record High in 1H 2022, Benefiting From Global Resource Optimization

Q2 2022 Financial Highlights: * Revenue was RMB 7.46 billion, an increase of 4.9% year on year. A record high second quarter in the company's history. * Generated RMB 1.04 billion cash from operations. With net capex investments ofRMB 0.64 billion, free cash flow for the quarter was RMB 0.4 b...

2022-08-18 22:03 4535

Ping An Health posts revenue of RMB2,828 million in the first half of 2022

Gross margin improves to 27.3% Cumulative paying users reaches over 40 million HONG KONG and SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or "Ping An Health"; Stock Code: 1833.HK), announced its 2022 interim results. Since the de...

2022-08-18 21:53 4402

JCET Performance Hits Another Record High in 1H 2022, Benefiting From Global Resource Optimization

Q2 2022 Financial Highlights: * Revenue was RMB 7.46 billion, an increase of 4.9% year on year. A record high second quarter in the company's history. * Generated RMB 1.04 billion cash from operations. With net capex investments ofRMB 0.64 billion, free cash flow for the quarter was RMB 0.4 b...

2022-08-18 21:38 3741

Henlius 2022 H1 Results: Sharpen all-round edges, advance in evolution to Biopharma

SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- Henlius (2696.HK) announced its 2022 interim results. As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, affordable and innovative biopharmaceuticals to patients worldwide with 5 products launched inChina, 1 in ...

2022-08-18 21:35 4450

Adyen advances in-person payments with the launch of in-house designed terminal range

* The company is releasing two new terminals, the NYC1 and the AMS1, after expanding into designing hardware for the first time  * The terminals are affordable and flexible solutions that simplify accepting in-person payments for enterprise and platform businesses AMSTERDAM, Aug. 18, 2022 /PR...

2022-08-18 21:25 5704

Yeahka Limited to Report 2022 Interim Results on Tuesday, August 30, 2022

HONG KONG, Aug. 18, 2022 /PRNewswire/ -- Yeahka Limited ("Yeahka" or the "Company", stock code: 9923.HK), a leading payment-based technology platform in China, today announced that it will report its unaudited financial results for the 6 months endedJune 30, 2022. The Company's management wi...

2022-08-18 21:24 4781

Autoliv, Inc. appoints Gustav Lundgren to Board of Directors and Declares Quarterly Dividend

STOCKHOLM, Aug. 18, 2022 /PRNewswire/ -- The Board of Directors of Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), pursuant to the previously disclosed agreement with Cevian Capital II GP Limited ("Cevian"), today appointedGustav Lundgren to the Board of Directors, replacing Min Liu who resigned.  Th...

2022-08-18 20:50 2667

Pixelworks Announces Strategic Investment in Shanghai Subsidiary

PORTLAND, Ore., Aug. 18, 2022 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW) (the "Company"), a leading provider of innovative video and display processing solutions, today announced that it entered into an Equity Transfer Agreement with a group of private equity investors based inChina ("Purcha...

2022-08-18 19:40 4503

IBM and USTA Announce Multi-Year Partnership Renewal Ahead of 2022 US Open

Redesigned USOpen.org and US Open App will Include New Fan Experiences Leveraging Hybrid Cloud and Explainable AI  ARMONK, N.Y., Aug. 18, 2022 /PRNewswire/ -- IBM (NYSE: IBM ) and the United States Tennis Association (USTA) today announced a five-year renewal of...

2022-08-18 18:00 3345

Cloud Music Inc. Reports First Half 2022 Financial Results

HANGZHOU, China, Aug. 18, 2022 /PRNewswire/ -- Cloud Music Inc. (HKEX: 9899 or the "Company"), a leading interactive music streaming service provider inChina, today announced its financial results for the first half of 2022 ended30 June 2022. Summary of Key Financial and Operating Metrics (RMB ...

2022-08-18 16:50 3716

With the World's Top Growth Rate, Yili Group Once Again Secures its Place Among the Top Five

HOHHOT, China, Aug. 18, 2022 /PRNewswire/ -- On August 17, Rabobank published its 2022 Global Dairy Top 20 Report, which showed that Yili Group remains among the global top five with turnover[1] ofUSD 18.2 billion, firmly holding onto its top leadership position inAsia for the ninth consecutive y...

2022-08-18 15:11 5066
1 ... 764765766767768769770 ... 904